Follow The Filings

JKS

Earnings company data as of 4:49 AM ET 10/23

Scheduled

2 periods, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 16 Nov EPS — — —
Rev — — —
FY2026 Q2 26 Aug EPS -0.70 — —
Rev — — —

Insider trades

Open-market buys and sales by JKS's executives, directors and 10% owners in the last 12 months, from their Form 4s

All JKS insider trades
  • $50K bought by 1 insider
  • $33.4M sold by 3 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Wing Keong Siew Director
    Sale
    $264K 16,000 shares at $16.49 8.6% of stake
    Traded Jun 30 Filed Jul 2
  2. Stephen Markscheid Director
    Sale
    $50K 2,000 shares at $25.00 9.1% of stake
    Traded May 13 Filed May 20
  3. Stephen Markscheid Director
    Buy
    $50K 2,000 shares at $25.00 +11% to stake
    Traded May 13 Filed May 19
  4. Wing Keong Siew Director
    Sale
    $418K 16,000 shares at $26.11 7.9% of stake
    Traded May 13 Filed May 15
  5. Xianhua Li Director
    Sale
    $32.7M 1,280,000 shares at $25.53 11% of stake
    Traded May 13 Filed May 15

Also filed in the last 12 months, not counted as buying or selling: 6 stock grants.

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
6-K FORM 6-K
424B3 —
6-K FORM 6-K
6-K FORM 6-K
SCHEDULE 13D/A —
6-K FORM 6-K
6-K FORM 6-K
6-K FORM 6-K
6-K FORM 6-K
6-K FORM 6-K
6-K FORM 6-K
20-F
6-K FORM 6-K
6-K FORM 6-K
6-K FORM 6-K
6-K FORM 6-K
6-K FORM 6-K
6-K FORM 6-K
6-K FORM 6-K
6-K FORM 6-K
6-K FORM 6-K
6-K FORM 6-K
6-K FORM 6-K
6-K FORM 6-K
6-K FORM 6-K

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.